1. Molecular and immune heterogeneity in synchronous melanoma metastases
- Author
-
Marie-Andree Forget, Alexandre Reuben, Christine N. Spencer, Michael Davies, Parra Cuentas, Rodabe N. Amaria, Whijae Roh, Scott E. Woodman, Edwin Roger, Vancheswaran Gopalakrishnan, Yu Cao, Lawrence N. Kwong, Karen C. Dwyer, Lynda Chin, Pei-Ling Chen, John P. Miller, Chantale Bernatchez, Jennifer A. Wargo, Latasha Little, Jaime Rodriguez, Andrew Futreal, Hong Jiang, Haven R. Garber, Jason Roszik, Cara Haymaker, Jacob Austin-Breneman, Zachary A. Cooper, James P. Allison, Padmanee Sharma, and Michael T. Tetzlaff
- Subjects
Pharmacology ,Oncology ,Cancer Research ,medicine.medical_specialty ,Metastatic melanoma ,business.industry ,Melanoma ,medicine.medical_treatment ,Immunology ,Immunotherapy ,Bioinformatics ,medicine.disease ,Immune system ,Internal medicine ,Poster Presentation ,medicine ,Molecular Medicine ,Immunology and Allergy ,business - Abstract
Meeting abstracts Despite recent advances in the treatment of metastatic melanoma through targeted and immunotherapy, the majority of patients do not achieve a durable response. Research efforts to better understand responses are underway, and numerous molecular mechanisms of resistance to targeted
- Full Text
- View/download PDF